Yahoo
ASX - Delayed Quote AUD

Nanosonics Limited (NAN.AX)

3.0300 +0.0400 (+1.34%)
At close: October 30 at 4:10:11 PM GMT+11
Chart Range Bar
Loading chart for NAN.AX
  • Previous Close 2.9900
  • Open 3.0000
  • Bid 3.0000 x --
  • Ask 3.0300 x --
  • Day's Range 2.9900 - 3.0600
  • 52 Week Range 2.6400 - 4.5800
  • Volume 379,843
  • Avg. Volume 1,080,700
  • Market Cap (intraday) 906.478M
  • Beta (5Y Monthly) 1.15
  • PE Ratio (TTM) 50.50
  • EPS (TTM) 0.0600
  • Earnings Date Aug 25, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 3.88

Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

www.nanosonics.com.au

508

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

NAN.AX
23.68%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

NAN.AX
33.84%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

NAN.AX
18.77%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

NAN.AX
48.82%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

3.20
3.88 Average
3.0300 Current
5.15 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.75%

  • Return on Assets (ttm)

    3.68%

  • Return on Equity (ttm)

    8.35%

  • Revenue (ttm)

    203.89M

  • Net Income Avi to Common (ttm)

    17.84M

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    155.22M

  • Total Debt/Equity (mrq)

    10.63%

  • Levered Free Cash Flow (ttm)

    -72.38k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: